Article Details

Experts on Second-Line Treatment Options for EGFR TKI-Resistant NSCLC - OncLive

Retrieved on: 2022-12-24 05:55:27

Tags for this article:

Click the tags to see associated articles and topics

Experts on Second-Line Treatment Options for EGFR TKI-Resistant NSCLC - OncLive. View article details on hiswai:

Excerpt

... and the chief of Medical Oncology and associate cancer center director of Translational Science at Yale Cancer Center, Smilow Cancer Hospital.

Article found on: www.onclive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up